CLINICAL_TRIALS
trial_result
· 2012-11-30
Clinical Trial Update: Confirmatory Study Nepafenac 0.3% [Phase 3]
Summary
Phase 3 confirmatory study of nepafenac 0.3% ophthalmic solution for cataract surgery has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Cataract | Phase 3 | Status: COMPLETED | Results posted: 2012-11-30